SEC 13F Intelligence

Sofinnova Investments, Inc. / RYTM

Sofinnova Investments, Inc.’s Rhythm Pharmaceuticals Inc Position

Does Sofinnova Investments, Inc. own Rhythm Pharmaceuticals Inc (RYTM)? Yes — 450.1K shares worth $39M (+1.49% of its 13F portfolio) as of Q1 2026, up from 271.4K shares the prior filed quarter.

Position Value
$39M
Q1 2026
Shares
450.1K
% of Portfolio
+1.49%
Quarters Held
8
currently held

Position History RYTM

Reported value by quarter
Q4 ’19: $489,000Q4 ’19Q3 ’24: $14MQ3 ’24Q4 ’24: $22MQ4 ’24Q1 ’25: $24MQ1 ’25Q2 ’25: $37MQ2 ’25Q3 ’25: $25MQ3 ’25Q4 ’25: $29MQ4 ’25Q1 ’26: $39MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026450.1K$39M+1.49%
Q4 2025271.4K$29M+1.25%
Q3 2025247.0K$25M+1.36%
Q2 2025586.0K$37M+2.26%
Q1 2025446.8K$24M+1.55%
Q4 2024397.4K$22M+1.62%
Q3 2024276.7K$14M+1.15%
Q4 201921.3K$489,000+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sofinnova Investments, Inc.’s full portfolio or all institutional holders of RYTM.